Skip to main content

Continuous ambulatory peritoneal dialysis in 224 diabetics with end stage renal disease: evidence of improved survival over the past 10 years

  • Chapter
Diabetic Renal-Retinal Syndrome

Abstract

Dating back to its earliest application in diabetic ESRD patients, Oreopoulos has championed peritoneal dialysis. In the present update of an experience with 224 diabetic patients, peritonitis, the technique limiting complication of peritoneal dialysis, was reduced to about one episode in 16–19 months, an impressive accomplishment. Survival increased to a remarkable 93% at one year and 70% after three years. By five years, however, two-thirds of patients were dead, the consequence of unrelenting comorbidity. Assigning a place for peritoneal dialysis as opposed to hemodialysis as a first choice regimen for diabetic patients with ESRD is more a matter of bias and personal experience than of objective data analysis. In Canada, 52% of diabetic patients were receiving peritoneal dialysis three months after initiation of dialytic therapy while in the United States fewer than 20% are similarly treated. Why? Enthusiasts like Oreopoulos have advanced acceptance of peritoneal dialysis by demonstrating that it can be performed with high patient acceptance, lower cost than hemodialysis, and superior patient survival. Lacking the commitment and expertise of physicians dedicated to peritoneal dialysis, nephrologists are unlikely to gain results that meet the standard of excellence exemplified by the present report.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Valderabano F, Jones EHP, Mallick NP. Report on management of renal failure in Europe XXIV, 1993. Nephrol Dial Transplant 1995; 10(Suppl 5): 1–25.

    Google Scholar 

  2. USRDS (United States Renal Data System) Annual data report. USRDS, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda. Am J Kidney Dis 1995; 26(Suppl 2): S1–S186.

    Google Scholar 

  3. USRDS (United States Renal Data System) Annual data report. USRDS, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda. 1997.

    Google Scholar 

  4. Thompson T, Fisher M, Hatfield P et al. Diabetic end stage renal failure — the Wellington experience 1975-1988. Aust NZ J Med 1991; 21: 29–35.

    Article  CAS  Google Scholar 

  5. Grenfell A, Bewick M, Snoweden S, Warkins P, Parsons V. Renal replacement for diabetic patients: experience at King College Hospital. 1980-1989. Q J Med 1992; 85: 861–874.

    PubMed  CAS  Google Scholar 

  6. Schaubel D, Fenton SSA. Diabetes and Renal Failure. Section 6. Canadian Organ Replacement Register. Annual report 1996. Canadian Institute of Health Information, Ottawa, Ontario. March 1996.

    Google Scholar 

  7. Friedman EA. Renal Syndromes in Diabetes. Endocrinol Metab Clin N Am 1996; 2(25): 293–324.

    Article  Google Scholar 

  8. Balaskas EV, Yuan ZY, Gupta A, Meema HE, Blair G, Bargman J, Oreopoulos DG: Long-term continuous ambulatory peritoneal dialysis in diabetics. Clin Nephrol 1994; 42: 54–62.

    PubMed  CAS  Google Scholar 

  9. Viglino G, Cancarini GC, Catizone L, Cocchi R, De Vecchi A, Lupo A, Salomone M, Segolini GP, Giangrande A. Ten years experience of CAPD in diabetics; comparison of results with non-diabetics. Nephrol Dial Transplant 1994; 9: 1443–1448.

    PubMed  CAS  Google Scholar 

  10. Zimmerman SW, Johnson CA, O’Brien M. Long-term survivors on peritoneal dialysis. Am J Kidney Dis 1987; 10: 241–249.

    PubMed  CAS  Google Scholar 

  11. Zimmerman S. The diabetic ESRD patient: Specific needs. Perit Dial Int 1997; 17: (Suppl 3): S9–S11.

    PubMed  Google Scholar 

  12. Amair P, Khanna R, Leibel B. et al. Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease. In: Friedman EA, L’Esperance FA (eds.), Diabetic Retinal Syndrome, Prevention and Management; 1981: 331–343.

    Google Scholar 

  13. Humphrey LL, Ballard DJ, Frohnert PP et al. Chronic renal failure in non-insulin-depended diabetes mellitus. Ann Intern Med 1989; 10: 788–796.

    Google Scholar 

  14. Mauer SM, Chavers BM. A comparison of kidney disease in type I and type II diabetes. Adv Exp Med Biol 1985; 189: 299–303.

    PubMed  CAS  Google Scholar 

  15. Melton LJ, Palumbo PJ, Chu CP. Incidence of diabetes mellitus by clinical type. Diabetes Care 1983; 6: 75–86.

    Article  PubMed  Google Scholar 

  16. Legrain M, Rottembourg J, Bentchikou A et al. Dialysis treatment of insulin dependent diabetic patient: Ten years experience. Clin Nephrol 1984; 21: 72.

    PubMed  CAS  Google Scholar 

  17. Khanna R, Wu G, Prowant B, Jastrzebska J, Nolph KD, Oreopoulos DG. Continuous Ambulatory Peritoneal Dialysis in Diabetics with End-Stage Renal Disease: A Combined Experience of Two North American Centers. In: Friedman EA, L’Esperance FA (eds.), Diabetic Retinal Syndrome 3; 1986: 363–381.

    Google Scholar 

  18. Levin ME. The diabetic foot. A primer for nephrologist. Semin Dial 1991; 4: 258–264.

    Article  Google Scholar 

  19. Kemperman FAW, vanLeusen R, van Liebergen FJHM et al. Continuous Ambulatory Peritoneal Dialysis (CAPD) in patients with diabetic nephropathy. Neth J Med 1991; 38:236–245.

    PubMed  CAS  Google Scholar 

  20. Rottenbourg J, Issad B, Allouache M, Baumelou A, Deray G, Jacobs C. Clinical aspects of continuous ambulatory and continuous cyclic peritoneal dialysis in diabetic patients. Perit Dial Int 1989; 9: 289–294.

    Google Scholar 

  21. Yuan ZY, Balaskas EV, Gupta A, Bargman JM, Oreopoulos DG. Is CAPD or Hemodialysis better/ CAPD is more advantageous. Semin Dial 1992; 5: 181–188.

    Article  Google Scholar 

  22. Khanna R: Peritoneal dialysis in diabetic end-stage renal disease. In: Gokal R, Nolph KD (eds.), The Textbook of Peritoneal Dialysis. Dordrecht, Kluwer Academic Publishers, 1994; 639–659.

    Chapter  Google Scholar 

  23. Khanna R. Dialysis considerations for diabetic patients. Kidney Int 1993; 43(Suppl 40): S58–S64.

    Google Scholar 

  24. Tzamaloukas AH, Oreopoulos DG. Sabcutaneous versus intraperitoneal insulin in the management of diabetes on CAPD. A review. Adv Perit Dial 1991; 7: 81–85.

    PubMed  CAS  Google Scholar 

  25. Di Paolo B, Di Liberato L, Fiederling B et al. Incidence and pathophysiology of hypertension in continuous ambulatory peritoneal dialsysis. Perit Dial Int 1993; 13(Suppl 2): 396–398.

    Google Scholar 

  26. Stablein DM, Hamburger RJ, Lindbland AS, Nolph KD, Novak JW. The effect of CAPD on Hypertension control; a report of the National CAPD Registry. Perit Dial Int 1998; 8: 141–144.

    Google Scholar 

  27. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 1996; 7: 198.

    Google Scholar 

  28. Davies SJ, Bryan J, Phillips L, Russel GI. The predictive value of KT/V and peritoneal solute transport in CAPD patients is dependent on the type of comorbidity present. Perit Dial Int 1996; 16: S158–S162.

    PubMed  Google Scholar 

  29. Churchill DN, Taylor DW, Keshavian PR. Adequacy of dialysis and nutrition in continuous ambulatory peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996; 7: 198–207.

    Google Scholar 

  30. Blake P, Burkart MJ, Churhill ND et al. Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int 1996; 16: 5:448–456.

    PubMed  CAS  Google Scholar 

  31. Giovanni C, Brunori G, Zani R, et al. Long-term outcomes of peritoneal dialysis. Perit Dial Int 1997; 17(Suppl2): S115–S118.

    Google Scholar 

  32. Rottembourg J, Issad B, Allouache M et al. Clinical aspects of continuous ambulatory and continuous cyclic peritoneal dialysis in diabetic patients. Perit Dial Int 1989; 9(4): 289–294.

    PubMed  CAS  Google Scholar 

  33. Coronel F, Hortal L, Naranjo P et al. Analysis of factors in the prognosis of diabetics on continuous ambulatory peritoneal dialysis (CAPD): long-term experience. Perit Dial Int 1989; 9(2): 121–125.

    PubMed  CAS  Google Scholar 

  34. Maiorca R, Cancarini GC, Brunori G, Camerini C, Manili L. Morbidity and mortality of CAPD and hemodialysis. Kidney Int Suppl 1993 Feb; 40: S4–S15.

    PubMed  CAS  Google Scholar 

  35. Zimmerman SW, Oxton LL, Bidwell D, Wakeen M. Long-term outcome of patients receiving peritoneal dialysis. Perit Dial Int 1996 Jan; 16(1): 63–68.

    PubMed  CAS  Google Scholar 

  36. Churchill DN, Thorpe EK, and Teehan PB for the Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Treatment of Diabetics with End Stage Renal Disease: Lessons from the Canada-USA (CANUSA) Study of Peritoneal Dialysis. Semin Dial 1997; 10(4) (July-August): 215–218.

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Pasadakis, P.S., Oreopoulos, D.G. (1998). Continuous ambulatory peritoneal dialysis in 224 diabetics with end stage renal disease: evidence of improved survival over the past 10 years. In: Friedman, E.A., L’Esperance, F.A. (eds) Diabetic Renal-Retinal Syndrome. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4962-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-4962-4_8

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6083-7

  • Online ISBN: 978-94-011-4962-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics